International Conference on
Emerging Cell Therapies
October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA
Untitled Document
Cell Therapy-2012

    Previous Events
     
     
    Participants List from Academia
    Untitled Document
    Kansas State University, USA

    Deakin University, Australia

    University of Texas, USA

    University of North Carolina, USA

    DRDO, Ministry of Defence, India

    Anderson Cancer Center, USA

    University of Texas, USA

    Weill Medical College of Cornell University, USA

    University Feinberg School of Medicine, USA

    McGill University, USA

    Purdue University, USA

    The South Western Medical Center, USA

    Kunming Medical College, China

    Banaras Hindu University, India

    University of Washington, USA

    Istanbul Bilim University, Turkey

    Georgetown University School of Medicine, USA

    Louisiana state University, USA

    Royal Victoria Hospital, USA

    University Hospital Ulm, Germany

    Universita degli Studi di Milano, Italy

    San Diego Regenerative Medicine Institute & Xcelthera, San Diego, USA

    Queensland University of Technology, Australia

    Zagazig University, Egypt

    Seoul National University, South Korea

    Kansas State University, USA

    MD Anderson Cancer Center, USA

    Australian Institute of Physics, USA

    St. Mary’s University of MN , USA

    Tulane Cancer Center , USA

    TVanderbilt University Medical Center , USA

    University Hospital Ulm , Germany

    Emory University School of Medicine , USA

    University of Texas , USA

    Purdue University , USA

    San Diego Regenerative Medicine Institute & Xcelthera , USA

    Queensland University of Technology, Australia

    Deakin University, Australia

    University of Pavia, Italy

    Bharathiar University, India

    Universidad Autonoma de Nuevo Leon, Mexico

    Nelson Mandela University, South Africa

    Seoul National University, South Korea

    Universita degli Studi di Milano, Italy

    Zagazig University, Egypt

    Tata Memorial Hospital, India

    Kaohsiung Medical University, Taiwan

    Children’s Hospital Bambino Gesu , Italy

    Tanta University , Egypt

    The Weizmann Institute , Israel

    Tehran university , Iran

     
    Participants List From Business
    Untitled Document
    Cell Therapy Group, USA

    Bioheart Inc., USA

    Cellectis Stem Cells, Sweden

    Cord Blood Registry Inc., USA

    Reliance Life Sciences, India

    Biospherix., USA

    Hemo Genix, Inc, USA

    Bioheart Inc, USA

    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women's Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy's labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST), India

    Novartis Campus, Austria


     
    Upcoming Conferences
    Day 1
    Scientific Program
      Day 2
    Scientific Program
      Day 3
    Scientific Program
    International Conference on Emerging Cell Therapies, will be organized around the theme "Evolving Technology in Cell Therapy and its Future Perspectives".

    Cell Therapy-2012 is comprised of 9 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Emerging Cell Therapies.

    Submit your abstract to any of the following tracks.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Renowned Speakers
    speaker Samir A. Farghaly
    Weill Medical College of Cornell University, USA

    speaker Kapil Bharti
    National Institutes of Health, USA

    speaker Tarek El-Bialy
    University of Alberta, Canada

    speaker Kurt C Gunter
    International Society for Cellular Therapy, Canada

    speaker David T. Harris
    CSO, Cord Blood Registry Inc., USA

    speaker Ivan Rich
    CEO of HemoGenix Inc., USA

    speaker Madhusudan V. Peshwa
    MaxCyte Inc., , USA

    speaker Deryl Troyer
    Kansas State University, USA

    speaker Lee Buckler
    Cell Therapy Group, USA

    speaker Jagat R Kanwar
    Deakin University, Australia

    speaker Kristin Comella
    Bioheart Inc., USA

    speaker Christian X. Andersson
    Cellectis Stem Cells, Sweden

    speaker John M. Tomich
    Kansas State University, USA

    speaker Graeme Melville
    St George Hospital, Australia

    speaker Vasiliy Galat
    University Feinberg School of Medicine, USA

    speaker Prakash S. Bisen
    DRDO, Ministry of Defence, India

    speaker Kumudha Balakrishnan
    University of Texas, USA

    speaker Gary Guishan Xiao
    Genomics & Functional
    Proteomics Laboratories, USA

    speaker Nicolas Wickens
    Nelson Mandela University, South Africa

    speaker Zelig Eshhar
    The Weizmann Institute of Science, Israel

    speaker Ramin Lotfi
    University Hospital Ulm, Germany

    speaker Nady Celine Golestaneh
    Georgetown University School of Medicine, USA

    speaker Morayma Reyes
    University of Washington, USA

    Track 1: Cell Therapy- Potential Applications
    Track 1-1 Molecular therapy
    Track 1-2 Ocular therapy
    Track 1-3 Neuro therapy for neurological diseases
    Track 1-4 Cardiac cell therapy
    Track 1-5 Immunotherapy and its applications
    Track 1-6 Celltherapies for renal failure
    Track 2: Stem Cell Therapies
    Track 2-1 Molecular basis of pluripotency
    Track 2-2 Bone marrow stem cells as therapy
    Track 2-3 Current views of the embryonic and neural stem cells
    Track 2-4 Stem cell therapy for genetic disorders
    Track 2-5 Targeting stem cells for therapeutic benefits
    Track 2-6 Transplantation technologies in stem cell therapy
    Track 3: Cellular Therapies
    Track 3-1 Cell replacement verses molecular repair
    Track 3-2 Potential uses of defined cell populations
    Track 3-3 Reprogramming cell fate
    Track 3-4 Role of molecular markers in therapies
    Track 3-5 Target tissues and routes of delivery
    Track 3-6 Causes of regenerative failure
    Track 4: Cancer Therapies
    Track 4-1 Stem cells & cancer treatments
    Track 4-2 Characteristics of cancer cells
    Track 4-3 Cell cycle and oncology
    Track 4-4 Modern approaches in molecular cancer therapeutics
    Track 4-5 Genomics & cancer drug resistance
    Track 4-6 Targeted cancer therapy
    Track 4-7 Genetically engineered cancer vaccines
    Track 4-8 Challenges & risks of cancer gene therapy
    Track 5: Clinical Trials & Research in Cell Therapies
    Track 5-1 Principles of gene therapy & clinical gene therapy
    Track 5-2 Animal & human trials of engineered tissues
    Track 5-3 Emerging clinical aspects of stem cell therapy
    Track 5-4 Pharmacogenomics in cell therapy
    Track 5-5 Clinical trial design and analysis
    Track 5-6 Alternative lab models for cell therapy applications
    Track 6: Nanotechnology in Cell Therapies
    Track 6-1 Nano methods to target cancer cells
    Track 6-2 Nano-microfluidics in cell therapy
    Track 6-3 Nano materials and nano engineering
    Track 6-4 Pros and cons of molecular manufacturing
    Track 6-5 Nanovaccines
    Track 7: Bioengineering in Cell Therapeutics
    Track 7-1 Biomedical engineering
    Track 7-2 Developing new probes for tissue targeting
    Track 7-3 Therapeutic bioengineering
    Track 7-4 Cellular mechanobiology
    Track 7-5 Current understanding and challenges in bioprocessing
    Track 7-6 Bioengineering for medical diagnostics and imaging
    Track 8: Regulatory & Ethical Issues of Cell Therapy
    Track 8-1 Commercialisation strategy
    Track 8-2 Evolving regulatory requirements
    Track 8-3 Risks and cost involved in stem cell maintenance
    Track 8-4 Ethics involved in human stem cells
    Track 8-5 Logistics in preparing lab models for cell therapy applications
    Track 8-6 Manufacturing of cell therapy products and marketing guidelines
    Track 8-7 Databases, industry news, published reports
    Track 8-8 FDA & EMA guidelines
    Track 9: Current Research & Future Perspectives on Cell Therapy
    Track 9-1 Xenotransplantation
    Track 9-2 Innovative therapeutic technologies
    Track 9-3 Applications of cell therapy- from bench to bedside
    Track 9-4 Cell therapy in future medicine
    Track 9-5 Application of thermocycles in cell therapy
    Conference Secretariat: Cell Therapy-2012, OMICS Group Conferences
    5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA.
    Phone: +1-650-268-9744 l Fax: +1-650-618-1414
    Toll free: 1-800-216-6499(USA & Canada) l 1-800-651-097(Australia) l 0805-080048(Europe)
    Email: celltherapy2012@omicsgroup.info
    Operated by: Editors - Journal of Cell Science & Therapy and Journal of Cell and Developmental Biology
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version